Table 2.

Association of demographic characteristics with any and continuation benzodiazepine use among older adult patients of non-psychiatrist physicians in the U.S. from 2007–2010 (n=32,544 and n=1,748)

				Adjusteda
Demographic Characteristic	Visits with benzodiazepines (n=1,748)	Visits without benzodiazepines (n=30,796)	p	ORb	95% CI
Age
65–74 years, %c (ref)	45.3	50.0	n/a	1.00	n/a
75–84 years	38.5	37.0	.05	1.16	1.01–1.33
85+ years	16.2	13.0	.006	1.40	1.12–1.77
Sex
Male (ref)	31.7	43.7	n/a	1.00	n/a
Female	68.3	56.3	<0.001	1.61	1.38–1.88
Ethnicity
Non-Hispanic white (ref)	82.5	79.8	n/a	1.0	n/a
Non-Hispanic black	7.1	8.1	.29	.87	.67–1.13
Hispanic	8.3	8.9	.96	.99	.76–1.30
Other	2.1	4.0	.005	.52	.33–.82

				Adjusteda
Demographic Characteristic	Continuation benzodiazepines (n=1,559)	New benzodiazepines (n=189)	p	ORd	95% CI
Age
65–74 years, % (ref)	44.8	49.0	n/a	1.00	n/a
75–84 years	38.0	41.6	.99	.95	.62–1.45
85+ years	17.2	9.3	.09	1.96	.82–4.67
Sex
Male (ref)	31.2	35.2	n/a	1.00	n/a
Female	68.8	64.8	.55	1.21	.66–2.22
Ethnicity
Non-Hispanic white	83.6	75.3	n/a	1.00	n/a
Non-Hispanic black	6.2	13.6	.009	.38	.18–.78
Hispanic	8.4	7.4	.96	1.14	.45–2.90
Other	1.9	3.7	.11	.39	.15–1.06

^aAdjusted for diagnosis or reason for visit of anxiety and insomnia.

^bOR: odds ratio reflecting the odds associated with benzodiazepine use.

^cPercentage of visit with a given characteristic, unless noted otherwise.

^dReflects the odds associated with continuation benzodiazepine use.